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Background: A proactive integrated approach has shown to preserve daily functioning among older
people in the community. The aim is to determine the cost-effectiveness of a proactive integrated
primary care program.
Methods: Economic evaluation embedded in a single-blind, 3-armed, cluster-randomized controlled trial
with 12 months’ follow-up in 39 general practices in the Netherlands. General practices were ran-
domized to one of 3 trial arms: (1) an electronic frailty screening instrument using routine medical
record data followed by standard general practitioner (GP) care; (2) this screening instrument followed
by a nurse-led care program; or (3) usual care. Health resource utilization data were collected using
electronic medical records and questionnaires. Associated costs were calculated. A cost-effectiveness
analysis from a societal perspective was undertaken. The incremental cost per quality-adjusted life-
year was calculated comparing proactive screening arm with usual care, and screening plus nurse-led
care arm with usual care, as well as the screening arm with screening plus nurse-led care arm.
Results: Out of 7638 potential participants, 3092 (40.5%) older adults participated. Whereas effect differ-
ences were minor, the total costs per patient were lower in both intervention groups compared with usual
care. The probability of cost-effectiveness at V20,000 per QALY threshold was 87% and 91% for screening
plus GP care versus usual care and for screening plus nurse-led care compared to usual care, respectively.
For screening plus nurse-led care vs screening plus standard GP care, the probability was 55%.
Conclusion: A proactive screening intervention has a high probability of being cost-effective compared to
usual care. The combined intervention showed less value for money.
 2017 AMDA e The Society for Post-Acute and Long-Term Care Medicine. This is an open access article
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and Long-Term Care Medicine. ThWorldwide, the number of people aged 60 years and older will rise
from 600 million in 2000 to approximately 2 billion in 2050.1 A sub-
stantial number of these older people will experience frailty, that is, an
increased risk of adverse health outcomes.2 Frail older people often have
multiple chronic diseases and limitations in their activities of daily
living.3,4 With their resulting complex care needs, the elderly population
places a large burden on health care resources.5 In the United States, total
health care expenditures for people aged 65 were $368 billion in 2008,
which was almost one-third of the total health care budget.6 For people
with 5 or more chronic diseases, health care spending is often 14 times
higher than for people without any chronic disease.7is is an open access article under the CC BY-NC-ND license (http://creativecommons.
N. Bleijenberg et al. / JAMDA 18 (2017) 1029e10361030In the Netherlands, V33 billion (37%) of the total 2011 health care
budget of V89 billion was spent on care for people aged 65 years and
older.8 Because health care costs for older people place amajor burden on
society, the efficient delivery of care is important to ensure that as many
positive health effects as possible are realized for the money invested.
Most care needs of older people are addressed in primary care. As
gatekeepers to the health care system, general practitioners (GPs)
resolve more than 90% of the health problems in the overall popula-
tion.9 Based on the integrated, patient-centered approach and the
long-lasting relationship with their patients, GPs have a key role in the
provision and coordination of care for frail older patients.10 However,
at present, the care for older people in general practice is reactive and
fragmented, and the care needs of frail older people are not adequately
met.11,12 A paradigm shift is needed from reactive care, in which GPs
respond to emerging health problems of the high-needs, high-cost
individual a more proactive, population-based care provision.13,14
The current evidence for the cost-effectiveness of proactive primary
care for older people is scarce and difficult to compare across studies.15,16
We designed and implemented a strategy for proactive primary health
care for older people consisting of the systematic identification of frail
older people, and a subsequent nurse-led, proactive, and personalized
care program.17 The strategy demonstrated a small but significant effect
in delaying functional decline in the elderly population at 1-year follow-
up.18 The aim of the present studywas to evaluate the cost-effectiveness
of the Utrecht Proactive Frailty Intervention Trial (U-PROFIT) strategy




The economic evaluation was performed using data collected
alongside the U-PROFIT trial, which has been described elsewhere in
detail.19 In brief, we conducted a single-blind, 3-armed, cluster-
randomized controlled trial in 39 general practices in the Utrecht
region of the Netherlands. These general practices provide primary
health care to approximately 44,000 patients aged 60 years and older.
In this trial, we evaluated the effectiveness of the frailty screening
instrument followed by standard GP care, and that of the screening
followed by a nurse-led proactive care program on the level of daily
functioning among frail, community-dwelling older people compared
with the usual primary care. The U-PROFIT trial was approved by the
Institutional Review Board of the University Medical Center Utrecht
(protocol ID 10-149/O).
Interventions
Arm 1. The frailty screening intervention consists of a software
application that identifies patients at risk for frailty by screening
routine electronic medical record (EMR) data from general prac-
tices. Patients aged 60 years and older were considered potentially
frail and included in a quarterly report when they met at least 1 of
the following criteria: a frailty index 0.20,20,21 polypharmacy of
5 medications in chronic use, or a consultation gap (at least
3 years without general practice consultation except for the annual
influenza vaccination).22 In the screening plus standard GP care
arm, GPs were asked to use the reports proactively, following cur-
rent professional guidelines. For example, GPs were able to call
patients if they felt it was necessary because of the consultation gap
or comorbidities. In these practices, there was no trained registered
nurse to deliver the additional steps of the proactive care program.
Arm 2. In the second arm, the frailty screening was followed by the
nurse-led care intervention. Twenty-one registered practice nurses
were trained to deliver this proactive intervention. After the frailtyscreening based on EMR data, patients at risk received a self-report
questionnaire to measure the level of frailty using the Groningen
Frailty Indicator.23 Next, patients whowere identified as frail on the
Groningen Frailty Indicator received a home-based Comprehensive
Geriatric Assessment, followed by evidence-based care planning,
care coordination and follow-up.17 Care coordination and the
intensity of follow-up was based on patients care needs. Evidence-
based care plans were developed for 11 geriatric syndromes such as
falls, urinary incontinence, mobility, and nutrition.
Arm 3. The frailty screening was also performed in the control
group practices, but the report was not visible for the GPs. GPs in
the control group were asked to continue their usual care, based on
Dutch general practice guidelines. Most practices provided reactive
care to emerging health problems. Patients need a referral from the
GP to get access to secondary care or to see a medical specialist. In
some control group practices, nurses provided reactive and ad hoc
care to older people.
Participants
Within the participating general practices, we approached 7638
eligible patients, that is, patients aged 60 years and older who met at
least 1 of the frailty selection criteria based on the EMR record data as
described above. In total, 3092 patients (40.5%) provided written
informed consent. Individuals who were terminally ill, defined as
estimated life expectancy of 3 months or less, and those in assisted-
living facilities or nursing homes were excluded. Flowchart of the
participants is provided in Appendix A. Nonresponders were phoned
and, if needed, home visits were conducted for thosewho experienced
difficulty reading or filling in the questionnaire.
Design Cost-Effectiveness Study
For the current study, we performed an incremental cost-
effectiveness analysis from a societal perspective. We compared the 2
interventions for proactive care for frail older people as evaluated in the
U-PROFIT trial, that is, frailty screening followed by standard GP care and
frailty screening followed by nurse-led care, with usual care as the control
condition and among each other. We evaluated the costs and effects at
12 months, which is the full follow-up period of the U-PROFIT trial.
Because of this time frame, discounting of costs and effects was not
necessary.
Data Collection and Resource Valuation
Costs
Intervention costs. The costs of the frailty screening followed by
standard GP care and the frailty screening followed by nurse-led
care intervention were calculated using a bottom-up approach
(Appendix B). In brief, we collected information on the time
required for the interventions by the GPs and registered nurses and
the related costs based on their hourly wage costs. Information on
costs of electronic frailty screening start-up and maintenance, the
nurse-led care educational program for the registered nurses in
primary care, and an evidence-based toolkit developed and used by
the nurses was collected alongside the development and imple-
mentation of both interventions. Next, we calculated the number of
potentially frail older people per general practice based on the
frailty screening, assuming a standard Dutch practice size of 2350
patients.24 In a standard general practice, on average, 552 patients
(23.5%) are 60 years and older.25 Within this older population, 110
patients (20%) would be selected as potentially frail in frailty
screening based on routine primary care data.19 With these data,
we converted the calculated intervention costs to “costs per
potentially frail older patient per year.”
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we extracted EMR data on daytime GP consultations and
emergency department visits. With questionnaires at 12 months,
we collected data on the number of out-of-hours GP consultations
(ie, consultations with GPs during nights or weekend days and can
be either in-surgery or at-home consultations), hospital admis-
sions, permanent and temporary nursing home admissions and
residences in assisted living facilities, home care, and day care.19
With questionnaires at baseline, 6 months, and 12 months
directed at the patients’ informal caregivers, we gathered data on
how many hours per week patients received informal care. We
used the Dutch Manual for costing research in health care to value
the health care resources and provision of informal care in terms of
their unit costs (Table 1).26We indexed prices to the level of 2012.27
Effect measures. In the questionnaires at baseline, 6 months, and
12 months, we collected data on the patients’ health status using
the 3-level EuroQoL EQ-5D instrument.28 We applied the Dutch
EQ-5D tariff to calculate mean utility values for the different health
states derived from the EQ-5D responses.29
Statistical Analysis
We performed all analyses based on an intention-to-treat principle.
Using 5 factors (age, sex, marital status, frailty index, and self-rated
health) to predict the missing values, we employed multiple imputa-
tions to account for missing data in the health care utilization measures
and the EQ-5D.30e32 Next, we calculated the total costs for each patient
by multiplying the health care resources used by the respective unit
costs. In addition, we calculated the QALYs for each patient using anTable 1
Costs of Resource Use and Utilization in the Frailty Screening, Frailty Screening þ Nurse-
Type of Utilization Costs
Unit Unit Cos
Interventions
Frailty screening start-up and maintenance
expenses
Per patient/year 7.10
Frailty screening usage in proactive care
(direct patient consultations were valued
under “health care utilization”)
Per patient/year 20.90
Nurse-led care education, toolkit, website Per patient/year 1.65
Nurse-led care program usage in proactive
care (direct patient consultations excluded)
Per patient/year 101.30
Health care utilization
GP consultations (consultations per year) Per consultation 30.95*
GP consultation by telephone (consultations
per year)
Per consultation 14.90*
Out-of-hours GP consultations (consultations
per year)
Per consultation 98.30y
Home care (hours per week) Per hour 37.20*
Nursing home (days per year) Per day 252.75*
Assisted living facility (days per year) Per day 95.60*
Day care (days per week) Per day 47.80*
Emergency department visits (visits/year) Per visit 160.35*
Hospital admission (days in hospital/year) Per day 485.30*
Informal care
Care provided by informal caregiver (hours
per week)
Per hour 13.30*
Frailty Index score, median (IQR)
Number of medications during last year,
median (IQR)
Consultation gap in days, median (IQR)
IQR, interquartile range; N/A, not applicable.
Values reflect the imputed data of the study sample. Values are means (SD) unless state
*According to the Dutch manual for costing studies (Hakkaart-van Roijen, 2011).
yAccording to the Dutch Healthcare Authority (www.nza.nl). See “Details Resource V
terventions, health care utilization, and informal care provision.area under the curve approach with linear interpolation of the EQ-5D
utility values among the baseline, 6-month, and 12-month data.33 To
avoid bias in the QALY calculation, we corrected for imbalances in the
baseline EQ-5D utility values using a regression-based approach.34
Using the mean total costs and effects for each intervention arm, we
calculated the incremental cost-effectiveness ratios for arm 1 and arm 2
compared with usual care (arm 3) and for arm 2 compared with arm 1.
This base case analysis was performed from a societal perspective,
that is, including all assessed costs in the imputed data set and the
adjustedQALYs. To estimate the uncertainty around the incremental cost-
effectiveness ratios, we used bootstrapping with 1000 iterations. With
these bootstrapped cost-effect pairs, we constructed cost-effectiveness
planes and cost-effectiveness acceptability curves alongside a spectrum
of different amounts society would be willing to pay for 1 QALY. As is
common for this type of intervention in the Netherlands, we adopted a
willingness to pay (WTP) of V20,000 per QALY. To examine the robust-
ness of our results, we planned a number of sensitivity analyses: first, a
sensitivity analysis from the health care perspective, that is, excluding the
costs related to the provision of informal care; second, a sensitivity
analysis on complete cases only; and third, a sensitivity analysis using
QALYs unadjusted for baseline EQ-5D imbalances.
Results
Characteristics of the Study Population
The inclusion process and baseline characteristics of our study
population have been described in detail elsewhere.18 In brief, out of
3092 patients, 790 patients received the frailty screening intervention
followed by standard GP care (arm 1),1446 patients participated in theLed Care, and Control Arm
Mean Utilization (SD)
t (V) Frailty Screening þ
GP Care (n ¼ 790)
Frailty þ Nurse-Led







7.44 (5.48) 9.62 (6.94) 9.81 (8.38)
3.18 (4.14) 4.83 (5.52) 3.53 (4.71)
1.02 (1.87) 1.14 (2.21) 1.18 (2.18)
1.40 (4.36) 1.40 (2.70) 1.54 (5.15)
2.11 (20.15) 1.13 (8.88) 3.06 (16.59)
1.57 (12.55) 1.34 (10.04) 1.26 (10.19)
0.05 (0.40) 0.05 (0.40) 0.03 (0.36)
0.16 (0.46) 0.15 (0.47) 0.17 (0.50)
2.06 (5.92) 2.14 (6.66) 2.38 (5.59)
2.45 (9.92) 2.73 (11.50) 2.86 (11.70)
0.06 (0.02-0.10) 0.08 (0.04-0.10) 0.08 (0.06-0.12)
6 (5-8) 7 (5-8) 6 (5-8)
29 (13-64) 35 (21-64) 23 (10-50)
d otherwise. All costs are indexed to 2012.
aluation” for detailed information on the composition of the unit costs of the in-
Table 2
Mean Total Costs and Effects of the Frailty Screening, Frailty Screening þ Nurse-Led Care, and Usual Care at the 12-Month Follow-up
Variable Mean Total Effects or Costs (SD)
Frailty Screening þ GP Care Frailty þ Nurse-Led Care Usual Care
Costs (V)
Costs directly related to interventions, mean (SD) 28 (0) 131 (0) 0 (0)
Health care utilization costs, mean (SD) 4928 (11,427) 4806 (7512) 5621 (12,289)
Informal caregiver costs, mean (SD) 1695 (6861) 1888 (7950) 1980 (8092)
Total costs, mean (SD) 6651 (14,686) 6825 (11,452) 7601 (15,717)
Effects
EQ-5D utility value (complete cases)
Baseline, mean (SD) 0.742 (0.237) 0.725 (0.244) 0.747 (0.226)
6 months, mean (SD) 0.727 (0.254) 0.712 (0.262) 0.735 (0.256)
12 months, mean (SD) 0.707 (0.291) 0.702 (0.275) 0.721 (0.269)
EQ-5D utility value (imputed data)
Baseline, mean (SD) 0.741 (0.231) 0.724 (0.236) 0.746 (0.221)
6 months, mean (SD) 0.726 (0.246) 0.711 (0.252) 0.731 (0.248)
12 months, mean (SD) 0.703 (0.271) 0.699 (0.258) 0.714 (0.257)
QALYs
Imputed and unadjusted, mean (SD) 0.722 (0.225) 0.710 (0.224) 0.728 (0.223)
Imputed and adjusted, mean (SD) 0.698 (0.217) 0.709 (0.222) 0.703 (0.208)
N. Bleijenberg et al. / JAMDA 18 (2017) 1029e10361032frailty screening followed by nurse-led care intervention (arm 2), and
856 patients received care as usual (arm 3). The mean age of the study
population was 73.5 years (8.2 SD), and 55.3% was female. In total,
427 patients (13.8%) had an informal caregiver who was willing to
participate in the trial by answering the questionnaires targeted at
informal care provision. In arm 1, arm 2, and arm 3, 162 (20.5%), 299
(20.7%) and 142 (16.6%) patients, respectively, did not complete the
12-month follow-up.
In total, 10.4% of the EQ-5D data was missing, with 2508 patients
(81.1%) having complete EQ-5D data available. For the health care
utilization measures, 16.8% of the data from self-reports was missing,
with 2063 patients (66.7%) having complete data available. When
considering the total of 427 informal caregivers, data related to the
hours of provided care were missing for 14.6% of the provided
informal care, with 278 informal caregivers (65.1%) having complete
data available.
Health Care Utilization, Costs, and Effects
Patients in the frailty screening followed by standard GP care arm
had fewer GP consultations than patients in the other 2 arms, whereas
patients in the frailty screening plus nurse-led care arm had the
highest rate of GP consultations by telephone (Table 1). Furthermore,
patients in the frailty screening plus nurse-led care arm spent notably
fewer days in a nursing home than patients in the other 2 arms. ThereTable 3
Results of the Cost-Effectiveness Analyses: Frailty Screening Followed by GP Care Arm C
Analysis D Cost, V (95% CI) D Effect (95% CI)
Base case analysis
Societal perspective, adjusted QALYs 951 (2545 to 477) 0.0047 (0.0266 to
Sensitivity analyses
Health care perspective 655 (1761 to 455) 0.0047 (0.0253 to
Unadjusted QALYs 951 (2482 to 435) 0.0062 (0.0276 to
Complete cases (adjusted QALY) 2251 (6185 to 1870) 0.0025 (0.0219 to
D cost is the mean difference in the costs of 1000 bootstrapped samples. D effect is the
*Frailty screening is more effective and more costly than usual care.
yFrailty screening more effective and less costly than usual care (dominant).
zFrailty screening is less effective and less costly than usual care.
xFrailty screening is less effective and more costly than usual care (inferior).was also a trend toward fewer days in the hospital for both inter-
vention arms (Table 1). Over a 12-month period, patients in both the
frailty screening plus standard GP care and frailty screening plus
nurse-led care arm had lower health care utilization costs (V693 and
V815, respectively), compared to patients in the usual care group
(costs) (Table 2). When considering costs related to the hours of
informal care provided, patients in the frailty screening and frailty
screening plus nurse-led care arm had less costs (V285 and V92,
respectively) than patients of the usual care arm.
With intervention costs ofV28 for the frailty screening followed by
standard GP care andV131 for the frailty screening plus nurse-led care
included, the mean total costs in the intervention groups were lower
than that in the usual care group (mean costs per patient in
euros  SD) per group: frailty screening plus standard GP care arm:
6651 (14,686); frailty screening plus nurse-led care arm: 6825
(11,452); usual care: 7601 (15,717).
With regard to health effects, differences between groups were
significant but small, and of questionable clinical relevance. Without
adjustment for EQ-5D imbalances at baseline, patients in the frailty
screening plus nurse-led care arm had the lowest QALYs. After
correction for the different baseline EQ-5D scores between groups,
patients in the frailty screening plus nurse-led care arm had
slightly higher QALYs over the 1-year period than the patients in the
frailty screening plus standard GP care arm and usual care arm
(Table 2).ompared With Usual Care
Distribution Cost-Effectiveness Plane (Quadrant)
Northeast* Southeasty Southwestz Northwestx Probability (%) of
Cost-Effectiveness at
WTP of V20,000
0.0162) 0.01 0.31 0.60 0.07 87%
0.0166) 0.03 0.28 0.59 0.10 80%
0.0159) 0.01 0.28 0.62 0.09 84%
0.0244) 0.06 0.52 0.34 0.08 86%
mean difference in the effect of 1000 bootstrapped samples.
Fig. 1. Cost-effectiveness planes and cost-effectiveness acceptability curves (CEACs) for frailty screening followed by standard GP care vs usual care (A and B); frailty
screening þ nurse-led care vs usual care (C and D); and frailty screening þ nurse-led care vs frailty screening plus standard GP care (E and F).
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After bootstrapping, the frailty screening intervention followed by
standard GP care resulted in a cost saving of V951 [95% confidence
interval (CI) 2545 to 477] and a QALY loss of 0.0047 (95% CI e0.0266
to 0.0162) compared to usual care (Table 3). Among all the boot-
strapped data pairs, 60% were situated in the southwest quadrant of
the cost-effectiveness plane, indicating both lower effectiveness and
lower costs, whereas 31% pointed at dominance (ie, better health
outcomes at lower cost). The cost-effectiveness acceptability curve
demonstrated that at a WTP of V20,000, the probability ofcost-effectiveness of the frailty screening intervention followed by
standard GP care was 87% (Figure 1).
When the frailty screening plus nurse-led care intervention was
compared to usual care, cost savings of V776 (95% CI e2025 to 350)
and a QALY gain of 0.0063 (0.0112 to 0.0243) were generated,
resulting in dominance of the frailty screening plus nurse-led
care intervention over usual care (Table 4). Evaluating the cost-
effectiveness plane, 71% of the bootstrapped data pairs showed
higher effectiveness and lower costs, that is, superiority compared
with the usual care group. The probability of cost-effectiveness at a
WTP of V20,000 was 91% (Figure 1).
Table 4
Results of the Cost-Effectiveness Analyses: Frailty Screening þ Nurse-Led Care Arm Compared With the Usual Care Arm
Analysis D Cost, V (95% CI) D Effect (95% CI) Distribution Cost-Effectiveness Plane (Quadrant)
Northeast* Southeasty Southwestz Northwestx Probability (%) of
Cost-Effectiveness
at WTP of V20,000
Base case analysis
Societal perspective, adjusted QALYs 776 (2025 to 350) 0.0063 (0.0112 to 0.0243) 0.05 0.71 0.20 0.05 91%
Sensitivity analyses
Health care perspective 664 (1671 to 211) 0.0063 (0.0121 to 0.02614) 0.03 0.72 0.20 0.04 93%
Unadjusted QALYs 776 (2112 to 366) 0.0188 (0.0358 to 0.0009) 0.00 0.03 0.88 0.09 73%
Complete cases (adjusted QALY) 2806 (6335 to 196) 0.009 (0.0202 to 0.0203) 0.03 0.88 0.16 0.03 96%
D cost is the mean difference in the costs of 1000 bootstrapped samples. D effect is the mean difference in the effect of 1000 bootstrapped samples.
*Frailty screening þ nurse-led care more effective and more costly than usual care.
yFrailty screening þ nurse-led care more effective and less costly than usual care (dominant).
zFrailty screening þ nurse-led care less effective and less costly than usual care.
xFrailty screening þ nurse-led careless effective and more costly than usual care (inferior).
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program to the frailty screening resulted in extra costs ofV175 (95% CI
e1000 to 1342) and a QALY gain of 0.011 (95% CI e0.007 to 0.0312). In
the cost-effectiveness plane, 51% of bootstrapped data pairs showed
higher costs and higher effectiveness, whereas 37% of the data pairs
showed or indicated dominance. At a WTP of V20,000, the frailty
screening plus nurse-led care intervention had a probability of 55% to
be cost-effective compared to the frailty screening followed by
standard GP care (Table 5), which points at the fact that combined
frailty screening followed by the nurse-led care intervention is less
cost-effective than the frailty screening followed by standard GP care.Sensitivity Analyses
In the comparison of frailty screening followed by standard GP care
with usual care, sensitivity analyses revealed no major results that
were notably different from the base case analysis (Table 3). When
comparing the frailty screening plus nurse-led care intervention with
usual care in the sensitivity analysis with unadjusted QALYs, the
bootstrapped data pairs shifted on the cost-effectiveness plane from
dominance in the base case analysis to the majority being situated in
the southwest quadrant, indicating higher costs and lower benefits
(Table 4). However, the probability of being cost-effective stayed
relatively high at 73%. The probability of cost-effectiveness of the
frailty screening plus nurse-led care intervention compared to the
frailty screening intervention followed by standard GP care decreased
to 30% in the sensitivity analysis with unadjusted QALYs, whereas in
the analyses from a health care perspective, the probability of cost-
effectiveness increased to 69% (Table 5).Table 5
Results of the Cost-Effectiveness Analyses: Frailty Screening þ Nurse-Led Care Arm Com
Analysis D Cost (V) (95% CI) D Effect (95% CI)
Base case analysis
Societal perspective, adjusted QALYs 175 (1000 to 1342) 0.011 (0.007 to 0
Sensitivity analyses
Health care perspective 19 (883 to 790) 0.011 (0.007 to 0
Unadjusted QALYs 175 (1047 to 1354) 0.0126 (0.0327 to
Complete cases (adjusted QALY) 456 (4033 to 2872) 0.0064 (0.0134 to
D cost is the mean difference in the costs of 1000 bootstrapped samples. D effect is the
*Frailty screening þ nurse-led care more effective and more costly than frailty screen
yFrailty screening þ nurse-led care more effective and less costly than frailty screeni
zFrailty screening þ nurse-led care less effective and less costly than frailty screening
xFrailty screening þ nurse-led care less effective and more costly than frailty screeniDiscussion
In this cost-effectiveness analysis, we demonstrated that the frailty
screening intervention based on routine care data followed by
standard GP care is cost-effective compared with usual primary care.
However, in the comparisons of both intervention groups with the
usual care group, the differences were relativelyminor and of doubtful
clinical relevance. The magnitude of the incremental cost-
effectiveness ratio was mainly determined by the size of the cost
savings. As a stand-alone intervention, the frailty screening inter-
vention followed by standard GP care provides more value for money
than the combined frailty screening plus nurse-led care intervention
at 1-year follow-up.Comparison Literature
To optimize the care for frail older persons in the community and
reduce health care costs among this population, several complex
multicomponent interventions have been evaluated in the last decade
showing inconclusive results.35,36 Cost-effectiveness analysis of these
programs are rarely performed. A good comparison of our results with
those published previously is challenging because of many reasons
such as different intervention components, follow-up, perspective,
and implementation practice. When comparing our results to other
community-based interventions aimed to prevent disability, the
results in terms of cost-effectiveness are inconclusive. Fairhall et al
evaluated the (cost)-effectiveness of a multifactorial interdisciplinary
intervention to reduce frailty in 216 frail older adults aged 70 and
older in Australia. Their results pointed at better value for moneypared With Frailty Screening Followed by Standard GP Care Arm
Distribution Cost-Effectiveness Plane (Quadrant)
Northeast* Southeasty Southwestz Northwestx Probability (%) of
Cost-Effectiveness at
WTP of V20,000
.0312) 0.51 0.37 0.02 0.09 55%
.0302) 0.42 0.46 0.05 0.07 69%
0.0065) 0.05 0.07 0.33 0.56 30%
0.0256) 0.29 0.42 0.13 0.16 58%
mean difference in the effect of 1000 bootstrapped samples.
ing followed by standard GP care.
ng followed by standard GP care (dominant).
followed by standard GP care.
ng only (inferior).
N. Bleijenberg et al. / JAMDA 18 (2017) 1029e1036 1035compared with usual care, especially among the very frail. The
probability of both cost-savings and effectiveness was high.37 In
contrast, a similar intervention was developed in Dutch elderly
(N¼346) aged 70 and older and showed that the intervention led to an
increase in health care utilization, especially in primary care and
related costs without additional benefits. The authors provide several
explanations for the findings such as the relatively high standard of
primary care in the Netherlands as a result of the gatekeeping function
of the primary care physician and preventive care programs for
chronically ill people.36 Although overall, patients in the intervention
group had less health care costs than patients in the usual care group,
we observed an increased use of primary care in our study as well.
Strengths and Limitations
Our study has some limitations. First, we partly used self-reported
data, which increases the risk of underreporting service use because of
recall bias.38,39 This risk may be aggravated by using questionnaires with
a 12-month recall period in a vulnerable population of older people.
However, becausewe applied amodified informed consent procedure in
the U-PROFIT trial, patients were unaware of their group assignment.
Therefore, we assume that the risk of underreporting is equal among the
groups and unlikely to have influenced the incremental cost-
effectiveness ratios. Second, to fully assess the effect of these complex
interventions on health care utilization and QALYs, a longer follow-up
period would have been preferable, as proactive care may pay out
more profoundly in the longer run. However, for logistical reasons, such a
follow-up was not feasible, and there were not enough data available in
the literature to consider a modeling approach. Third, the EMR did not
distinguish between actions performed by the GP and those by regis-
tered nurses. However, we resolved this issue by using previously
published estimates of the time investments of GPs and nurses for the
proactive primary care of older people (Appendix B). Finally, we did
not take into account other effect measures. We considered a cost-
effectiveness analysis using the Katz-15 index, the questionnaire on
the activities of daily living, which was the primary outcome measure in
the U-PROFIT trial, as an outcome parameter. However, in the absence of
a threshold value for the WTP for 1 unit of improvement in activities of
daily living, drawing conclusions with relevance for both policymakers
and clinical practitioners would have been difficult.
The current study is unique because it was embedded in a robustly
designed, large cluster-randomized controlled trial evaluating the effec-
tiveness of proactive, personalized primary care on the level of daily
functioningof frail olderpeople.As theU-PROFIT trialwasapragmatic trial
embedded within routine primary care, it closely reflected daily clinical
practice, ensuring that the results of this cost-effectiveness analysis have
highpractical relevance.Theresultsarehighlygeneralizablebecauseof the
participationofa largenumberofdiversegeneralpractices fromboth rural
and urban areas. We used the societal perspective, employed a multiple
imputation strategy to account for missing data, corrected for baseline
imbalances in the EQ-5D, used an accurate bottom-up approach to
calculate the intervention costs, and performed various sensitivity
analyses to evaluate the robustness of our results.
Implications for Practice
Improving care for older patients with complex care needs and
multimorbidity is a high priority worldwide. Developing evidence-
based integrated care programs for people at high risk that are
(cost) effective is therefore crucial. Our results indicate that both in-
terventions have a high probability of being cost-effective compared
with usual primary care because of the cost-saving aspect. However,
because no significant health benefits were observed, the clinical
interpretation and long-term impact are unclear. Our hypothesis was
that the combined intervention, that is, the frailty screening followedby the nurse-led care intervention, would result in additional benefits
in terms of health and cost savings. However, adding the nurse-led
care intervention to the frailty screening had a low probability to be
cost-effective. Moreover, post hoc analyses showed that the
intervention effect was not different for participants enrolled on each
specific inclusion criteria (eg, polypharmacy, frailty index, and
consultation gap). This study showed that the frailty screening inter-
vention followed by standard GP care had the best value for money.
The relatively inexpensive frailty intervention resulted in increased
awareness among GPs and nurses about the presence of potentially
frail older people in their patient population.40 Adequate data
registration is a prerequisite because the frailty screening is based on
computerized extraction from routine care data.
The cost-effectiveness and clinical effectiveness beyond 12 months
are unknown. Because the implementation of complex interventions
in daily clinical practice always takes time, we hypothesize that the
cost savings and effects will at least consolidate or even increase after
12 months of follow-up. However, further studies are necessary to
evaluate this hypothesis.41 Much work needs to be done to determine
the effective components, and effort is needed to develop strategies
that are beneficial for those at high risk and in urgent need of targeted
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Interventions, Health Care Utilization, and Informal Care
Provision
General Approach Used Throughout the Unit Cost Calculations
First, in general, we defined the number of potentially frail older
people per general practice, assuming a standard Dutch practice size
of 2350 patients.1 On average, 552 patients (23.5%) in a standard
practice are 60 years and older.2 Within this older population, 110
patients (20%)were selected as potentially frail in the Frailty Screening
report.3 With these data, we converted all calculated intervention
costs to the unit “costs per potentially frail older patient per year.”
Second, in all calculations, we applied a VAT tariff of 21%. Third, for
surcharges related to items such as social obligations and vacation
bonuses on wages defined within collective labor agreements, we
apply 39% for practice nurses, and 35% for general practitioners.4
Fourth, for the below-mentioned calculation of the costs directly
related to the interventions, we have only taken into account the ac-
tions of the GPs and practice nurses, not involving direct patient
contact as this latter category is already covered in the administration
of health care utilization. Fifth, all costs mentioned in this appendix
have been indexed to 2012.5Unit Costs of the Frailty Screening Followed by Standard GP Care
and Frailty Screening Followed by Nurse-Led Care Intervention
Frailty screening followed by standard GP care start-up and
maintenance expenses
Scenarios given by different software development companies






One-time installation charges written
off over 3 years, per year
V181.50 V82.50 V132
Maintenance expenses per patient
per year*
V0.04 V0.40 V0.22
*Per patient in overall practice population.Adoption of the mean of the 2 scenarios:
(132 þ 0.22  2350)  1.21 ¼ V785.29 per standard general
practice, including VAT.
785.29/110 ¼ V7.10 per potentially frail older patient per year for
the frailty screening installation charges and maintenance expenses.
Frailty Screening Usage in Proactive Care
Assumption of a time investment of 1 hour per week for evaluating
the total frailty screening report and preparing proactive care ac-
cording to current professional guidelines (personal communication
of time estimation by Prof Numans, professor of general practice). The
assumption is that half of this time will be invested by the GP and the
remaining half by the practice nurse.
Wage costs, practice nurse6:
Salary scale 50, step 4 ¼ V18.54/h.
Hourly honorarium: 18.54  1.39 ¼ V25.77/h.
Wage costs, GP7,8:
Honorarium derived from tax data: V45.18/h.
Honorarium derived from collective labor agreement, step 4:
V47.73/h.
Mean honorarium, GP: V46.46/h.
Hourly honorarium: 46.46  1.35 ¼ V62.72/h.Taking the mean of the hourly wages of practice nurses and GPs:
(25.77 þ 62.77)/2 ¼ V44.27/weekly hour of frailty screening usage
in proactive care for all patients in the report.
44.27 52¼V2302.04/y of the frailty screening usage in proactive
care for all patients in the report.
2302.04/110 ¼ V20.90 per potentially frail older patient per year
for frailty screening usage in proactive care.
Total frailty screening intervention costs: 7.10 þ 20.90 ¼ V28 per
potentially frail older patient. This calculationwas performedwith the
exception of direct patient contacts, as these are taken into account
within the registered health care utilization.Nurse-Led Care Intervention: Education, Toolkit, and Website
Education
Based on the workload and number of potentially frail older pa-
tients per standard practice, 0.33 full-time equivalents (FTEs) of
practice nurse per general practice was estimated to be needed for
adequate provision of the nurse-led care program.
Costs of delivery of the educational program
Invoice for 48 hours of education of 21 practice nurses at the school
of advanced education: V5851.
5851/21 ¼ V279 educational costs per practice nurse.
279/3 ¼ V93 educational costs per general practice.
93/110 ¼ V0.85 per potentially frail older patient per year for the
education itself.
Costs of Time Investment of Practice Nurse in Educational Program
Time investment practice nurse ¼ 48 hours.
Hourly honorarium practice nurse ¼ V25.77.
48  V25.77 ¼ V1236.96 per practice nurse.
1236.96/3 ¼ V412.32 per general practice.
Deprivation of Time Investment Costs Over a Period of 5 Years,
Assuming a Necessity to Follow Education Every 5 Years
0.20  412.32 ¼ V82.46 per general practice per year.
82.46/110 ¼ V0.75 per potentially frail older patient per year for
the time investment of registered practice nurses in the education of
the nurse-led care program.
0.85 þ 0.75 ¼ V1.60 per potentially frail older patient per year.
Toolkit
Actual expenses (Invoice printing office) for 500 toolkits:
V2448.60.
2448.60/500 ¼ V4.90 per toolkit.
One practice nurse needs 1 toolkit, and 1 general practice needs
0.33 FTE registered practice nurses:
4.90/3 ¼ V1.63 per general practice.
1.63/110 ¼ V0.01 per potentially frail older patient per year for the
toolkit.
Website (this website is used by the practice nurse to register
patient questionnaire data)
First estimation website developer: V0.04/potentially frail older
patient per year.
Total costs for nurse-led care intervention, toolkit, and
website¼ 1.60þ 0.01þ0.04¼V1.65 per potentially frail older patient
per year.Nurse-Led Care Program Usage in Proactive Care
The time investments mentioned below are based on estimations
of the time investments of GPs and practice nurses for the provision of
N. Bleijenberg et al. / JAMDA 18 (2017) 1029e1036 1036.e3proactive care for older people, which have been published by a
cooperation of insurance companies.9
Time investment per year of GPs per potentially frail older patient:
57minutes. These 57minutes include consultations of the GPwith the
practice nurse, multidisciplinary consultations, and the preparation of
proactive care actions. Actions involving direct patient contact are
excluded because they are already taken into account in the health
care utilization costs.
Time investment per year of practice nurses per potentially frail older
patient: 97 minutes. These 97 minutes include consultations of the
practice nursewith theGP, the construction of tailored, personalized care
plans, multidisciplinary consultations, and administrative tasks. Again,
actions involving direct patient contact are excluded because they are
already accounted for in the health care utilization costs.
Costs of nurse-led care programusage in the proactive care by the GP:
Time investment: 57 minutes.
Hourly honorarium: V62.72 (see 2.2).
(57  62.72)/60 ¼ V59.58 per potentially frail older patient per
year.
Costs of nurse-led care program usage in the proactive care by the
practice nurse:
Time investment: 97 minutes.
Hourly honorarium: V25.77.
(97  25.77)/60¼ V41.66 per potentially frail older patient per year.
59.58 þ 41.66 ¼ V101.24 for the time investment of GPs and
practice nurses for nurse-led care program per potentially frail older
patient per year.
Total intervention costs for the frailty screening þ nurse-led care
strategy: V28 þ V1.65 þ V101.24 ¼ V131 per potentially frail older
patient. This calculation excludes the costs related to direct patient
contacts, as these are included in the health care utilization costs.References
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